English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
University of California Irvine Medical Center
Share :
ESMO 33
12 - 16 Sep 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
3 Dec 2008
Views:
15092
Rating:
Save
Rate video
Prof. Bradley Monk
Promising new treatment option for women with recurrent ovarian cancer.
Categories:
Ovary & gynaecology
Related Videos
Novel therapies and combinations in ovarian cancer
Dr Alexandria Leary - Institute Gustave Roussy, Villejuif, France
25 Jan 2024
The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa
Dr Ntokozo Ndlovu - University of Zimbabwe, Harare, Zimbabwe
9 Jan 2024
The Lancet Commission on women, power, and cancer: Patient Stories
Prof Jennifer Moodley - University of Cape Town, Cape Town, South Africa
8 Jan 2024
Gender inequity in ovarian cancer research in resource limited settings
Dr Khalid El Bairi - Mohamed First University, Oujda, Morocco
21 Dec 2023
Synthetic biology and precision medicine in blood and gynaecological cancers
Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria...
21 Dec 2023
Low-dose olanzapine after highly emetogenic chemotherapy can be the new...
Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India
7 Dec 2023
First-line chemotherapy with atezolizumab and bevacizumab significantly...
Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain
4 Dec 2023
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for...
Prof Ignace Vergote - UZ Leuven, Leuven, Belgium
7 Nov 2023
Pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in...
Prof Domenica Lorusso - Fondazione IRCCS National Cancer Institute, Milan, Italy
7 Nov 2023
More from
e
cancer